 Stephen Duntley
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polysomnography | 15 | 2018 | 174 | 1.520 |
Why?
| | Electroencephalography | 8 | 2014 | 409 | 1.060 |
Why?
| | Sleep Apnea, Obstructive | 11 | 2018 | 275 | 1.050 |
Why?
| | Restless Legs Syndrome | 3 | 2012 | 21 | 1.010 |
Why?
| | REM Sleep Behavior Disorder | 2 | 2011 | 14 | 0.730 |
Why?
| | Electrocardiography | 3 | 2018 | 611 | 0.700 |
Why?
| | Sleep Apnea Syndromes | 5 | 2015 | 82 | 0.670 |
Why?
| | Sleep, REM | 5 | 2011 | 34 | 0.650 |
Why?
| | Neurodegenerative Diseases | 2 | 2011 | 113 | 0.640 |
Why?
| | Antidepressive Agents | 2 | 2011 | 229 | 0.630 |
Why?
| | Sleep | 7 | 2011 | 687 | 0.600 |
Why?
| | Sleep Wake Disorders | 3 | 2013 | 252 | 0.580 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 427 | 0.560 |
Why?
| | Epilepsy | 2 | 2011 | 322 | 0.530 |
Why?
| | Sleep Deprivation | 5 | 2013 | 171 | 0.520 |
Why?
| | Sleep Stages | 4 | 2018 | 45 | 0.500 |
Why?
| | Arousal | 3 | 2011 | 150 | 0.430 |
Why?
| | Drosophila Proteins | 2 | 2012 | 185 | 0.420 |
Why?
| | Disorders of Excessive Somnolence | 5 | 2015 | 30 | 0.370 |
Why?
| | Myoclonus | 1 | 2011 | 13 | 0.360 |
Why?
| | Sleep Apnea, Central | 1 | 2011 | 11 | 0.360 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2011 | 34 | 0.350 |
Why?
| | Iron | 1 | 2012 | 282 | 0.330 |
Why?
| | Coronary Disease | 3 | 2007 | 385 | 0.330 |
Why?
| | Cerebral Cortex | 3 | 2014 | 439 | 0.320 |
Why?
| | Dopamine | 1 | 2012 | 285 | 0.320 |
Why?
| | Heart Rate | 4 | 2007 | 802 | 0.300 |
Why?
| | Carrier Proteins | 1 | 2012 | 745 | 0.290 |
Why?
| | Irritable Bowel Syndrome | 1 | 2007 | 28 | 0.280 |
Why?
| | Status Epilepticus | 1 | 2007 | 42 | 0.270 |
Why?
| | Celiac Disease | 1 | 2010 | 286 | 0.270 |
Why?
| | Oxygen | 2 | 2011 | 915 | 0.260 |
Why?
| | Intestine, Small | 1 | 2007 | 151 | 0.260 |
Why?
| | Sleep Initiation and Maintenance Disorders | 4 | 2013 | 151 | 0.260 |
Why?
| | Fibrinogen | 1 | 2007 | 163 | 0.250 |
Why?
| | Clonazepam | 1 | 2004 | 6 | 0.240 |
Why?
| | Depressive Disorder | 2 | 2006 | 367 | 0.230 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2004 | 86 | 0.220 |
Why?
| | Inflammation Mediators | 1 | 2007 | 505 | 0.220 |
Why?
| | Depression | 3 | 2007 | 1317 | 0.210 |
Why?
| | Models, Animal | 1 | 2004 | 378 | 0.200 |
Why?
| | Middle Aged | 21 | 2018 | 31136 | 0.200 |
Why?
| | Continuous Positive Airway Pressure | 4 | 2014 | 78 | 0.190 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2002 | 86 | 0.190 |
Why?
| | Brain | 2 | 2012 | 2673 | 0.190 |
Why?
| | Aged | 14 | 2018 | 22061 | 0.190 |
Why?
| | Seizures | 1 | 2004 | 401 | 0.180 |
Why?
| | Adult | 21 | 2018 | 35599 | 0.180 |
Why?
| | Somatosensory Cortex | 1 | 2001 | 36 | 0.180 |
Why?
| | Humans | 39 | 2018 | 129626 | 0.170 |
Why?
| | Female | 27 | 2018 | 68734 | 0.170 |
Why?
| | Male | 25 | 2018 | 63670 | 0.170 |
Why?
| | Prevalence | 5 | 2013 | 2564 | 0.150 |
Why?
| | Comorbidity | 4 | 2013 | 1547 | 0.140 |
Why?
| | Saliva | 2 | 2015 | 211 | 0.130 |
Why?
| | Sensitivity and Specificity | 2 | 2018 | 1843 | 0.110 |
Why?
| | Sodium Oxybate | 1 | 2014 | 4 | 0.110 |
Why?
| | Epilepsy, Absence | 1 | 2014 | 8 | 0.110 |
Why?
| | Cyclooxygenase 2 | 1 | 2015 | 176 | 0.110 |
Why?
| | Risk Factors | 8 | 2013 | 9786 | 0.110 |
Why?
| | Incidence | 2 | 2011 | 2641 | 0.110 |
Why?
| | Drosophila | 2 | 2013 | 141 | 0.110 |
Why?
| | C-Reactive Protein | 2 | 2007 | 400 | 0.110 |
Why?
| | Narcolepsy | 2 | 2011 | 21 | 0.110 |
Why?
| | Benzhydryl Compounds | 1 | 2014 | 66 | 0.110 |
Why?
| | Circadian Rhythm | 5 | 2011 | 413 | 0.100 |
Why?
| | Surveys and Questionnaires | 4 | 2011 | 5415 | 0.100 |
Why?
| | Amyloid beta-Peptides | 2 | 2013 | 211 | 0.100 |
Why?
| | Plaque, Amyloid | 1 | 2011 | 15 | 0.090 |
Why?
| | Algorithms | 2 | 2018 | 1616 | 0.090 |
Why?
| | Central Nervous System | 2 | 2011 | 255 | 0.090 |
Why?
| | Somnambulism | 1 | 2011 | 1 | 0.090 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2011 | 39 | 0.090 |
Why?
| | Memory, Short-Term | 1 | 2014 | 265 | 0.090 |
Why?
| | Chromosome Inversion | 1 | 2011 | 17 | 0.090 |
Why?
| | Antiparkinson Agents | 1 | 2011 | 28 | 0.090 |
Why?
| | Diphenhydramine | 1 | 2011 | 31 | 0.090 |
Why?
| | Cyclohexanecarboxylic Acids | 1 | 2011 | 22 | 0.090 |
Why?
| | Amines | 1 | 2011 | 37 | 0.090 |
Why?
| | Statistics as Topic | 3 | 2007 | 305 | 0.090 |
Why?
| | Amyloid | 1 | 2011 | 85 | 0.090 |
Why?
| | Chromosome Disorders | 1 | 2011 | 40 | 0.090 |
Why?
| | Chromosomes, Human, X | 1 | 2011 | 72 | 0.090 |
Why?
| | Receptors, Notch | 1 | 2011 | 84 | 0.090 |
Why?
| | Chromosomes | 1 | 2011 | 101 | 0.090 |
Why?
| | Oximetry | 1 | 2011 | 87 | 0.090 |
Why?
| | Genetic Linkage | 1 | 2011 | 298 | 0.080 |
Why?
| | Diet, Gluten-Free | 1 | 2010 | 42 | 0.080 |
Why?
| | Age Distribution | 1 | 2011 | 373 | 0.080 |
Why?
| | Sex Distribution | 1 | 2011 | 360 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 168 | 0.080 |
Why?
| | Cardiovascular Diseases | 2 | 2013 | 2006 | 0.080 |
Why?
| | Interleukin-6 | 3 | 2013 | 723 | 0.080 |
Why?
| | Family Health | 1 | 2011 | 198 | 0.080 |
Why?
| | Pedigree | 1 | 2011 | 487 | 0.080 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2010 | 59 | 0.080 |
Why?
| | Drosophila melanogaster | 2 | 2011 | 210 | 0.080 |
Why?
| | Hypnotics and Sedatives | 1 | 2011 | 175 | 0.080 |
Why?
| | Age of Onset | 1 | 2011 | 495 | 0.080 |
Why?
| | Intellectual Disability | 1 | 2011 | 155 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2014 | 10219 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 515 | 0.080 |
Why?
| | Postoperative Complications | 2 | 2013 | 2477 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 105 | 0.080 |
Why?
| | Rifamycins | 1 | 2007 | 5 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2011 | 3378 | 0.070 |
Why?
| | Serotonin Receptor Agonists | 1 | 2007 | 28 | 0.070 |
Why?
| | Epilepsy, Complex Partial | 1 | 2007 | 2 | 0.070 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 2007 | 4 | 0.070 |
Why?
| | Sleep Disorders, Circadian Rhythm | 2 | 2007 | 37 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2018 | 14522 | 0.070 |
Why?
| | Odds Ratio | 1 | 2010 | 1019 | 0.070 |
Why?
| | Adolescent | 4 | 2014 | 20412 | 0.070 |
Why?
| | Homeostasis | 1 | 2011 | 605 | 0.070 |
Why?
| | Breath Tests | 1 | 2007 | 87 | 0.070 |
Why?
| | Alzheimer Disease | 1 | 2013 | 514 | 0.070 |
Why?
| | Depressive Disorder, Major | 1 | 2011 | 345 | 0.070 |
Why?
| | Gastrointestinal Agents | 1 | 2007 | 60 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1432 | 0.070 |
Why?
| | Prospective Studies | 4 | 2014 | 7135 | 0.070 |
Why?
| | Pregnancy Outcome | 1 | 2009 | 391 | 0.070 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 75 | 0.070 |
Why?
| | Biological Clocks | 1 | 2006 | 40 | 0.060 |
Why?
| | Gene Expression | 1 | 2011 | 1465 | 0.060 |
Why?
| | Heart Conduction System | 1 | 2006 | 95 | 0.060 |
Why?
| | Academic Medical Centers | 1 | 2009 | 475 | 0.060 |
Why?
| | Pituitary Neoplasms | 1 | 2007 | 179 | 0.060 |
Why?
| | Models, Cardiovascular | 1 | 2006 | 191 | 0.060 |
Why?
| | Fatigue | 2 | 2004 | 318 | 0.060 |
Why?
| | Mass Screening | 1 | 2013 | 1190 | 0.060 |
Why?
| | Logistic Models | 1 | 2010 | 1986 | 0.060 |
Why?
| | Severity of Illness Index | 4 | 2009 | 2739 | 0.060 |
Why?
| | Nocturnal Myoclonus Syndrome | 1 | 2004 | 6 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1202 | 0.060 |
Why?
| | Indoles | 1 | 2007 | 383 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 1042 | 0.060 |
Why?
| | Pregnancy Complications | 1 | 2009 | 493 | 0.060 |
Why?
| | Animals | 7 | 2013 | 35391 | 0.060 |
Why?
| | Personality Inventory | 1 | 2004 | 139 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 1 | 2006 | 320 | 0.050 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2004 | 26 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1445 | 0.050 |
Why?
| | Herpesviridae Infections | 1 | 2005 | 141 | 0.050 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2005 | 95 | 0.050 |
Why?
| | Probability | 1 | 2004 | 306 | 0.050 |
Why?
| | Rats | 3 | 2013 | 5483 | 0.050 |
Why?
| | Learning | 2 | 2011 | 407 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2060 | 0.050 |
Why?
| | Patient Compliance | 1 | 2007 | 565 | 0.050 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 73 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2003 | 58 | 0.050 |
Why?
| | Cytomegalovirus Infections | 1 | 2005 | 189 | 0.050 |
Why?
| | Rape | 1 | 2003 | 39 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2004 | 334 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2004 | 209 | 0.050 |
Why?
| | Biomarkers | 5 | 2015 | 3968 | 0.050 |
Why?
| | Pilot Projects | 1 | 2007 | 1592 | 0.050 |
Why?
| | Body Mass Index | 2 | 2015 | 2274 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3394 | 0.050 |
Why?
| | Wakefulness | 3 | 2011 | 120 | 0.050 |
Why?
| | Signal Transduction | 2 | 2013 | 4931 | 0.050 |
Why?
| | Subdural Space | 1 | 2001 | 7 | 0.050 |
Why?
| | Aging | 1 | 2011 | 1778 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3262 | 0.040 |
Why?
| | Electrodes, Implanted | 1 | 2001 | 106 | 0.040 |
Why?
| | Postoperative Period | 2 | 2013 | 330 | 0.040 |
Why?
| | Health Status | 1 | 2004 | 756 | 0.040 |
Why?
| | Young Adult | 2 | 2014 | 12455 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2011 | 441 | 0.040 |
Why?
| | Central Nervous System Stimulants | 2 | 2011 | 154 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2002 | 505 | 0.040 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2003 | 811 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2013 | 1687 | 0.030 |
Why?
| | Apoptosis | 1 | 2004 | 2492 | 0.030 |
Why?
| | Hydroxybutyrates | 1 | 2014 | 14 | 0.030 |
Why?
| | Caspase 1 | 1 | 2015 | 143 | 0.030 |
Why?
| | Wakefulness-Promoting Agents | 1 | 2014 | 3 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2708 | 0.030 |
Why?
| | Anesthetics | 1 | 2014 | 66 | 0.030 |
Why?
| | Annexin A3 | 1 | 2013 | 1 | 0.030 |
Why?
| | Social Security | 1 | 2013 | 5 | 0.030 |
Why?
| | Prodromal Symptoms | 1 | 2013 | 14 | 0.030 |
Why?
| | CD11b Antigen | 1 | 2013 | 61 | 0.030 |
Why?
| | Circadian Clocks | 1 | 2013 | 45 | 0.030 |
Why?
| | Actigraphy | 1 | 2013 | 98 | 0.030 |
Why?
| | Time Factors | 3 | 2013 | 6555 | 0.020 |
Why?
| | Positive-Pressure Respiration | 2 | 2003 | 76 | 0.020 |
Why?
| | Mushroom Bodies | 1 | 2011 | 3 | 0.020 |
Why?
| | Caffeine | 1 | 2011 | 62 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2011 | 10 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2011 | 14 | 0.020 |
Why?
| | Mutation | 2 | 2013 | 3717 | 0.020 |
Why?
| | Thiazoles | 1 | 2011 | 117 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2011 | 29 | 0.020 |
Why?
| | Methamphetamine | 1 | 2011 | 55 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1947 | 0.020 |
Why?
| | Adenosine Deaminase | 1 | 2011 | 29 | 0.020 |
Why?
| | Aniline Compounds | 1 | 2011 | 97 | 0.020 |
Why?
| | Video Recording | 1 | 2011 | 163 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 851 | 0.020 |
Why?
| | Neuroglia | 1 | 2011 | 163 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 307 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2011 | 282 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2013 | 5075 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2014 | 1875 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2013 | 693 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 834 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 819 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 756 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1293 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1035 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2011 | 419 | 0.020 |
Why?
| | Depression, Postpartum | 1 | 2009 | 130 | 0.020 |
Why?
| | Cataplexy | 1 | 2007 | 6 | 0.020 |
Why?
| | Amylases | 1 | 2006 | 17 | 0.020 |
Why?
| | Phototherapy | 1 | 2007 | 31 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1685 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1418 | 0.020 |
Why?
| | Oscillometry | 1 | 2006 | 37 | 0.020 |
Why?
| | Causality | 1 | 2007 | 117 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7052 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 660 | 0.020 |
Why?
| | Premature Birth | 1 | 2009 | 317 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2009 | 869 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2011 | 1125 | 0.010 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2004 | 15 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1326 | 0.010 |
Why?
| | Clonidine | 1 | 2004 | 27 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 419 | 0.010 |
Why?
| | Up-Regulation | 1 | 2006 | 840 | 0.010 |
Why?
| | Missouri | 1 | 2003 | 69 | 0.010 |
Why?
| | Neurons | 1 | 2011 | 1494 | 0.010 |
Why?
| | Computer Simulation | 1 | 2006 | 939 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2750 | 0.010 |
Why?
| | Sampling Studies | 1 | 2002 | 96 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 381 | 0.010 |
Why?
| | Semantics | 1 | 2002 | 100 | 0.010 |
Why?
| | Leg | 1 | 2003 | 239 | 0.010 |
Why?
| | Health Behavior | 1 | 2007 | 743 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2002 | 154 | 0.010 |
Why?
| | Sex Factors | 1 | 2006 | 1970 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2000 | 37 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1001 | 0.010 |
Why?
| | Stroke | 1 | 2009 | 1071 | 0.010 |
Why?
| | Hypertension | 1 | 2009 | 1243 | 0.010 |
Why?
| | Memory | 1 | 2002 | 266 | 0.010 |
Why?
| | Age Factors | 1 | 2006 | 3152 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2002 | 1017 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 6417 | 0.010 |
Why?
| | United States | 1 | 2013 | 13871 | 0.010 |
Why?
|
|
Duntley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|